Comparison of medication adherence and persistence in type 2 diabetes: A systematic review and meta-analysis - PubMed (original) (raw)
Meta-Analysis
. 2018 Apr;20(4):1040-1043.
doi: 10.1111/dom.13160. Epub 2017 Dec 12.
Affiliations
- PMID: 29135080
- DOI: 10.1111/dom.13160
Meta-Analysis
Comparison of medication adherence and persistence in type 2 diabetes: A systematic review and meta-analysis
Andrew McGovern et al. Diabetes Obes Metab. 2018 Apr.
Abstract
Limited medication adherence and persistence with treatment are barriers to successful management of type 2 diabetes (T2D). We searched MEDLINE, EMBASE, the Cochrane Library, the Register of Controlled Trials, PsychINFO and CINAHL for observational and interventional studies that compared the adherence or persistence associated with 2 or more glucose-lowering medications in people with T2D. Where 5 or more studies provided the same comparison, a random-effects meta-analysis was performed, reporting mean difference (MD) or odds ratio (OR) for adherence or persistence, depending on the pooled study outcomes. We included a total of 48 studies. Compared with metformin, adherence (%) was better for sulphonylureas (5 studies; MD 10.6%, 95% confidence interval [CI] 6.5-14.7) and thiazolidinediones (TZDs; 6 studies; MD 11.3%, 95% CI 2.7%-20.0%). Adherence to TZDs was marginally better than adherence to sulphonylureas (5 studies; MD 1.5%, 95% CI 0.1-2.9). Dipeptidyl peptidase-4 inhibitors had better adherence than sulphonylureas and TZDs. Glucagon-like peptide-1 receptor agonists had higher rates of discontinuation than long-acting analogue insulins (6 studies; OR 1.95; 95% CI 1.17-3.27). Long-acting insulin analogues had better persistence than human insulins (5 studies; MD 43.1 days; 95% CI 22.0-64.2). The methods used to define adherence and persistence were highly variable.
Keywords: GLP-1 analogue; antidiabetic drug; insulin analogues; medication adherence; medication persistence; meta-analysis; systematic review; type 2 diabetes.
© 2017 John Wiley & Sons Ltd.
Similar articles
- Real-world adherence, persistence, and in-class switching during use of dipeptidyl peptidase-4 inhibitors: a systematic review and meta-analysis involving 594,138 patients with type 2 diabetes.
Ogundipe O, Mazidi M, Chin KL, Gor D, McGovern A, Sahle BW, Jermendy G, Korhonen MJ, Appiah B, Ademi Z, De Bruin ML, Liew D, Ofori-Asenso R. Ogundipe O, et al. Acta Diabetol. 2021 Jan;58(1):39-46. doi: 10.1007/s00592-020-01590-w. Epub 2020 Aug 18. Acta Diabetol. 2021. PMID: 32809070 - Systematic review of adherence rates by medication class in type 2 diabetes: a study protocol.
McGovern A, Tippu Z, Hinton W, Munro N, Whyte M, de Lusignan S. McGovern A, et al. BMJ Open. 2016 Feb 29;6(2):e010469. doi: 10.1136/bmjopen-2015-010469. BMJ Open. 2016. PMID: 26928029 Free PMC article. - Comparison of glucose-lowering agents after dual therapy failure in type 2 diabetes: A systematic review and network meta-analysis of randomized controlled trials.
Zaccardi F, Dhalwani NN, Dales J, Mani H, Khunti K, Davies MJ, Webb DR. Zaccardi F, et al. Diabetes Obes Metab. 2018 Apr;20(4):985-997. doi: 10.1111/dom.13185. Epub 2018 Jan 8. Diabetes Obes Metab. 2018. PMID: 29205774 - Glycemic effectiveness and medication adherence with fixed-dose combination or coadministered dual therapy of antihyperglycemic regimens: a meta-analysis.
Han S, Iglay K, Davies MJ, Zhang Q, Radican L. Han S, et al. Curr Med Res Opin. 2012 Jun;28(6):969-77. doi: 10.1185/03007995.2012.684045. Epub 2012 May 3. Curr Med Res Opin. 2012. PMID: 22494018 Review. - Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
Hemmingsen B, Schroll JB, Lund SS, Wetterslev J, Gluud C, Vaag A, Sonne DP, Lundstrøm LH, Almdal T. Hemmingsen B, et al. Cochrane Database Syst Rev. 2013 Apr 30;(4):CD009008. doi: 10.1002/14651858.CD009008.pub2. Cochrane Database Syst Rev. 2013. PMID: 23633364 Updated. Review.
Cited by
- Intense simplified strategy for newly diagnosed type 2 diabetes in patients with severe hyperglycaemia: multicentre, open label, randomised trial.
Liu L, Ke W, Li H, Li F, Fan G, Kuang J, Ma J, Zhang X, Ji B, Li S, Du Y, Xue Y, Lyu Z, Gao L, Qu S, Shi Y, Yan L, Deng W, Xu C, Dai P, Xu L, Liu J, Wan X, Wei G, Yu S, Hong S, Zhang P, Huang Z, Cao X, Liao Z, Xiao H, Mu Y, Handelsman Y, Li Y. Liu L, et al. BMJ. 2024 Oct 15;387:e080122. doi: 10.1136/bmj-2024-080122. BMJ. 2024. PMID: 39406449 Free PMC article. Clinical Trial. - Metformin's Enigma: Bridging Gaps in Research on Potential Benefits & Associated Risks - A Critical Plea for Comprehensive Investigation [Response to Letter].
Dutta S, Shah RB, Singhal S, Dutta SB, Bansal S, Sinha S, Haque M. Dutta S, et al. Drug Des Devel Ther. 2024 Sep 7;18:4029-4031. doi: 10.2147/DDDT.S491638. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 39268391 Free PMC article. No abstract available. - Prevalence of adherence to oral antidiabetic drugs in patients with type 2 diabetes: A systematic review and meta-analysis.
Boonpattharatthiti K, Songkla PN, Chantara J, Koomsri C, Krass I, Chaiyakunapruk N, Dhippayom T. Boonpattharatthiti K, et al. J Diabetes Investig. 2024 Nov;15(11):1614-1625. doi: 10.1111/jdi.14285. Epub 2024 Aug 12. J Diabetes Investig. 2024. PMID: 39133204 Free PMC article. - A consensus statement from the Japan Diabetes Society (JDS): a proposed algorithm for pharmacotherapy in people with type 2 diabetes-2nd Edition (English version).
Bouchi R, Kondo T, Ohta Y, Goto A, Tanaka D, Satoh H, Yabe D, Nishimura R, Harada N, Kamiya H, Suzuki R, Yamauchi T; JDS Committee on Consensus Statement Development. Bouchi R, et al. Diabetol Int. 2024 Jul 11;15(3):327-345. doi: 10.1007/s13340-024-00723-8. eCollection 2024 Jul. Diabetol Int. 2024. PMID: 39101173 - 2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association.
Moon JS, Kang S, Choi JH, Lee KA, Moon JH, Chon S, Kim DJ, Kim HJ, Seo JA, Kim MK, Lim JH, Song YJ, Yang YS, Kim JH, Lee YB, Noh J, Hur KY, Park JS, Rhee SY, Kim HJ, Kim HM, Ko JH, Kim NH, Kim CH, Ahn J, Oh TJ, Kim SK, Kim J, Han E, Jin SM, Bae J, Jeon E, Kim JM, Kang SM, Park JH, Yun JS, Cha BS, Moon MK, Lee BW. Moon JS, et al. Diabetes Metab J. 2024 Jul;48(4):546-708. doi: 10.4093/dmj.2024.0249. Epub 2024 Jul 26. Diabetes Metab J. 2024. PMID: 39091005 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical